ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176323 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176323; 2) Community: the network communities that were significantly associated with the response to NSC 176323; 3) Molecule: the relationships between components within communities and NSC 176323; 4) MDR: the compounds that were significantly associated with the NSC 176323.

NSC Compound Enrichment Correlation
NSC 56410 Porfiromycin 0.00485717408280859 0.56314422
NSC 619196 Null 0.00485717408280859 0.21851571
NSC 718630 Null 0.00485717408280859 0.60126936
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.00485717408280859 0.62488915
NSC 134727 MITOMYCIN C 0.00485717408280862 0.56763081
NSC 674092 Quinoline-4-carboxamide, N,N'-[(1,4-piperazinediyl) bis(3,1-propanediyl)]bis(2-phenyl-, dihydrochloride 0.00485717408280864 0.016972178
NSC 26980 Mitomycin 0.0048681766467277 0.65294819
NSC 295501 Camptothecin Derivative 0.0048681766467277 0.75248538
NSC 633398 Null 0.0048681766467277 0.13129991
NSC 681637 Camptothecin Derivative 0.0048681766467277 0.81474598
Total:54  Current:8    [First] [Prev] [Next] [Last]